These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18004079)

  • 41. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
    Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
    Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.
    Gao Q; Wang XY; Qiu SJ; Yamato I; Sho M; Nakajima Y; Zhou J; Li BZ; Shi YH; Xiao YS; Xu Y; Fan J
    Clin Cancer Res; 2009 Feb; 15(3):971-9. PubMed ID: 19188168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma.
    Shengbing Z; Feng LJ; Bin W; Lingyun G; Aimin H
    Anat Rec (Hoboken); 2009 Aug; 292(8):1128-34. PubMed ID: 19645016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of major hepatectomy for large hepatocellular carcinoma.
    Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
    Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
    Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
    J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of clusterin in human hepatocellular carcinoma.
    Kang YK; Hong SW; Lee H; Kim WH
    Hum Pathol; 2004 Nov; 35(11):1340-6. PubMed ID: 15668890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patients.
    Chen CH; Hu FC; Huang GT; Lee PH; Tsang YM; Cheng AL; Chen DS; Wang JD; Sheu JC
    Eur J Cancer; 2009 Jun; 45(9):1630-9. PubMed ID: 19157858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
    Nakazawa T; Adachi S; Kitano M; Isobe Y; Kokubu S; Hidaka H; Ono K; Okuwaki Y; Watanabe M; Shibuya A; Saigenji K
    Oncology; 2007; 73(1-2):90-7. PubMed ID: 18337620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histone deacetylase 1 is required for cell cycle exit and differentiation in the zebrafish retina.
    Stadler JA; Shkumatava A; Norton WH; Rau MJ; Geisler R; Fischer S; Neumann CJ
    Dev Dyn; 2005 Jul; 233(3):883-9. PubMed ID: 15895391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adaptation of hepatectomy for huge hepatocellular carcinoma.
    Taniai N; Yoshida H; Tajiri T
    J Hepatobiliary Pancreat Surg; 2008; 15(4):410-6. PubMed ID: 18670843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.
    Kim BK; Han KH; Park YN; Park MS; Kim KS; Choi JS; Moon BS; Chon CY; Moon YM; Ahn SH
    J Surg Oncol; 2008 Mar; 97(3):246-52. PubMed ID: 18095300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
    Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
    Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.